Novavax has appointed Dr. Robert Walker, MD, as Executive Vice President (EVP) and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer (CEO) of Novavax.

A specialist in internal medicine and pulmonary and critical care medicine, Dr. Walker has over 30 years of experience in drug and vaccine development within the private and public sectors, including roles at the Biomedical Advanced Research and Development Authority in the U.S. Department of Health and Human Services, where he was Chief Medical Officer (CMO).

He is a seasoned R&D leader and has been instrumental in the development of Novavax's R&D strategy since joining the company in 2022, most recently serving as CMO. In this capacity, Dr. Walker has played a senior leadership role in advancing the company's vaccine and adjuvant development efforts, strengthening scientific and clinical execution and fostering a culture of collaboration and excellence across the entire R&D organisation.

"Bob has demonstrated deep scientific expertise, strong leadership and an unwavering commitment to advancing Novavax's technology platform and mission to innovate and collaborate to tackle some of the world's most significant health challenges. This appointment reflects the strength of our internal senior talent and signals the confidence of our Board and leadership team in Bob's ability to lead our R&D organisation as we continue to advance partnerships, drive innovation and create long-term value from our technology," said John C. Jacobs, President and Chief Executive Officer (CEO), Novavax.

Dr. Walker succeeds Dr. Ruxandra Draghia-Akli, who has departed the company to pursue other opportunities. 

In his new role, Dr. Walker will oversee Novavax's pre-clinical and clinical research and development functions, with a focus on advancing the company's scientific efforts and supporting continued scientific rigour and efficient operational excellence. Dr. Walker earned his Doctor of Medicine degree from the University of Maryland. He completed his internal medicine training at The George Washington University and completed his fellowship in pulmonary and critical care medicine at the University of Pennsylvania.